The chin augmentation market has seen considerable growth due to a variety of factors.
• The chin augmentation market has expanded steadily in recent years. It will grow from $1.14 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.9%.
This growth is driven by a rising awareness of aesthetics, increasing use of virtual consultations, growing awareness of facial aesthetics, and a focus on facial balance and harmony.
The chin augmentation market is expected to maintain its strong growth trajectory in upcoming years.
• The chin augmentation market is expected to reach $1.57 billion by 2029 at a CAGR of 6.6%.
Growth drivers include the increasing demand for cosmetic procedures, aesthetic consciousness, and financial accessibility to aesthetic treatments. Major trends include the development of next-generation dermal fillers, technological advancements in surgical techniques, and innovations in medical technologies.
The increasing number of cosmetic procedures is expected to spur the growth of the chin augmentation market. These procedures, aimed at enhancing appearance, are gaining popularity due to societal emphasis on looks and advancements in medical technology. Chin augmentation helps improve facial symmetry and balance, making it a sought-after cosmetic procedure. According to the International Society of Aesthetic Plastic Surgery, the number of aesthetic procedures increased by 3.4% in 2023, with a 5.5% rise in surgical procedures. This increase in cosmetic procedures is propelling the chin augmentation market.
The chin augmentation market covered in this report is segmented –
1) By Procedure: Surgical, Non-Surgical
2) By Material Type: Implants, Dermal Fillers, Fat Grafting, Other Materials
3) By Gender: Female, Male
4) By End-Use: Hospitals, Cosmetic Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Surgical: Chin Implant Surgery, Genioplasty (Bone Surgery)
2) By Non-Surgical: Dermal Filler Injections, Botox Injections, Thread Lifts
In the chin augmentation market, companies are developing advanced solutions like hyaluronic acid (HA) dermal fillers to meet the rising demand for non-surgical facial enhancements. HA dermal fillers are injected into the skin to add volume and improve facial contours. For example, in March 2024, US-based AbbVie received FDA approval for its JUVÉDERM VOLUMA, an injectable gel for deep injection to correct age-related volume loss in the mid-face and augment the chin region for adults over 21.
Major companies operating in the chin augmentation market are:
• AbbVie Inc.
• Stryker Corporation
• Galderma Filler
• Merz Pharma Gmbh and Co. Kgaa
• InMode Ltd.
• KLS Martin Group
• OsteoMed
• Sientra Inc
• GC Aesthetics Limited
• Hans Biomed
• POLYTECH Health and Aesthetics
• Implantech Associates Inc
• Sebbin Sas
• Teoxane
• Solta Medical Inc
• Silimed
• Lucid Implants
• Surgiform Technologies
• Facial Plastic Surgery Inc
• Eurosurgical Ltd
• Cadogan Clinic Ltd
North America was the largest region in the chin augmentation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chin augmentation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.